EGRX logo

Eagle Pharmaceuticals, Inc. (EGRX)

Profile

Full Name

Eagle Pharmaceuticals, Inc.

Ticker

NASDAQ: EGRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

February 12, 2014

Indexes

Not included

Website

https://www.eagleus.com

Employees

134

Key Details

Price

$3.20(-0.31%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$316.61M(+84.56% YoY)

Annual EPS

$2.73(+513.64% YoY)

PE ratio

3.52

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.20
    EGRX price is $3.20

    30-Day Relative Volume

    13.49
    EGRX 30-day relative volume is 13.49

    Price Performance

    Price Most recent change

    -0.31%
    EGRX price was down -0.31% on Sep 11, 2025

    Price YTD change

    +540%
    EGRX price is up +540% since January 1st

    Price 1-year change

    -16.45%
    EGRX price is down -16.45% year-on-year

    Price 3-year change

    -89.69%
    EGRX price is down -89.69% over the past 3 years

    Price Range

    Price All-time high

    $104.17
    EGRX price is currently -96.93% below its historical high of $104.17

    Price 3-year low

    $0.00
    EGRX price is currently >+9900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $41.56M
    EGRX market capitalization is $41.56 million

    Market cap 3-year change

    -89.92%
    EGRX market capitalization is down -89.92% over the past 3 years

    Market cap All-time high

    $1.57B
    EGRX market capitalization is currently -97.35% below its historical high of $1.57 billion

    Market cap sector rank

    29.75%
    EGRX market capitalization is higher than 29.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    EGRX shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -2.24%
    EGRX shares outstanding is down -2.24% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.41
    EGRX beta is 0.41

    200-day SMA

    $1.86
    EGRX price is currently +72.20% above its 200-day simple moving average

    50-day SMA

    $3.33
    EGRX price is currently -4.00% below its 50-day simple moving average

    RSI

    51.97
    EGRX 14-day relative strength index is 51.97

    Volume

    13.49
    EGRX 30-day relative volume is 13.49

    ATR

    $0.35
    EGRX average true range is $0.35

    10-day Historical Volatility

    36.48%
    EGRX 10-day historical volatility is 36.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $316.61M
    EGRX annual revenue is $316.61 million

    Revenue Analysts estimate

    -
    EGRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +84.56%
    EGRX annual revenue is up +84.56% year-on-year

    Revenue Sector rank

    77.85%
    EGRX annual revenue is higher than 77.85% of companies in Healthcare sector

    EPS

    EPS

    $2.73
    EGRX annual earnings per share is $2.73

    EPS Analysts estimate

    -
    EGRX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +513.64%
    EGRX annual earnings per share is up +513.64% year-on-year

    EPS Sector rank

    93.36%
    EGRX annual earnings per share is higher than 93.36% of companies in Healthcare sector

    Profit

    Gross profit

    $221.03M
    EGRX annual gross profit is $221.03 million

    Gross margin

    69.81%
    EGRX annual gross profit margin is 69.81%

    Operating profit

    $93.56M
    EGRX annual operating income is $93.56 million

    Operating margin

    -0.64%
    EGRX annual operating profit margin is -0.64%

    Net income

    $35.64M
    EGRX annual net profit is $35.64 million

    Net margin

    11.26%
    EGRX annual net profit margin is 11.26%

    Expenses

    Total expenses

    $280.97M
    EGRX annual total expenses is $280.97 million

    Operating expenses

    $127.47M
    EGRX annual total operating expenses is $127.47 million

    Cost of goods sold

    $95.58M
    EGRX annual cost of goods sold is $95.58 million

    Selling, general & administrative expenses

    $106.63M
    EGRX annual SGA is $106.63 million

    Depreciation and amortization

    $13.27M
    EGRX annual depreciation & amortization is $13.27 million

    Interest expense

    $0.00
    EGRX annual interest expense is $0.00

    Income tax

    $25.79M
    EGRX annual income tax is $25.79 million

    EBIT & EBITDA

    EBIT

    $93.56M
    EGRX annual earnings before interest & taxes is $93.56 million

    EBITDA

    $106.83M
    EGRX annual EBITDA is $106.83 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $406.16M
    EGRX annual total assets is $406.16 million

    Non current assets

    $217.41M
    EGRX annual long term assets is $217.41 million

    Current assets

    $188.75M
    EGRX annual total current assets is $188.75 million

    Cash and cash equivalents

    $55.32M
    EGRX annual cash & cash equivalents is $55.32 million

    Accounts receivable

    $72.44M
    EGRX annual accounts receivable is $72.44 million

    Inventory

    $53.26M
    EGRX annual inventory is $53.26 million

    Liabilities

    Total liabilities

    $172.60M
    EGRX annual total liabilities is $172.60 million

    Long term liabilities

    $61.51M
    EGRX annual total long term liabilities is $61.51 million

    Current liabilities

    $111.09M
    EGRX annual total current liabilities is $111.09 million

    Accounts payable

    $18.99M
    EGRX annual accounts payable is $18.99 million

    Debt

    Total debt

    $65.51M
    EGRX annual total debt is $65.51 million

    Total debt 1-year change

    +119.69%
    EGRX annual total debt is up +119.69% year-on-year

    Long term debt

    $57.72M
    EGRX annual long term debt is $57.72 million

    Short term debt

    $7.78M
    EGRX annual short term debt is $7.78 million

    Equity & Capital

    Shareholders equity

    $233.56M
    EGRX annual stockholders equity is $233.56 million

    Book value

    $233.56M
    EGRX annual book value is $233.56 million

    Retained earnings

    $111.50M
    EGRX annual retained earnings is $111.50 million

    Working capital

    $77.67M
    EGRX annual working capital is $77.67 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $50.70M
    EGRX annual cash flow from operations is $50.70 million

    Cash from operations 1-year change

    +79.67%
    EGRX annual cash flow from operations is up +79.67% year-on-year

    Cash from investing

    -$86.83M
    EGRX annual cash flow from investing activities is -$86.83 million

    Cash from investing 1-year change

    -1531.22%
    EGRX annual cash flow from investing activities is down -1531.22% year-on-year

    Cash from financing

    -$6.21M
    EGRX annual cash flow from financing activities is -$6.21 million

    Cash from financing 1-year change

    +78.13%
    EGRX annual cash flow from financing activities is up +78.13% year-on-year

    CAPEX

    CAPEX

    $178.00K
    EGRX annual capital expenditures is $178.00 thousand

    CAPEX 1-year change

    -44.89%
    EGRX annual capital expenditures is down -44.89% year-on-year

    Free Cash Flow

    Free cash flow

    $50.52M
    EGRX annual free cash flow is $50.52 million

    Free cash flow 1-year change

    +81.11%
    EGRX annual free cash flow is up +81.11% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.81%
    EGRX annual gross profit margin is 69.81%

    Operating margin

    -0.64%
    EGRX annual operating profit margin is -0.64%

    Net margin

    11.26%
    EGRX annual net profit margin is 11.26%

    ROA & ROE

    ROA

    10.77%
    EGRX annual return on assets is 10.77%

    ROE

    17.39%
    EGRX annual return on equity is 17.39%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    3.52
    EGRX price to earnings ratio is 3.52

    PE ratio Sector rank

    7.08%
    EGRX price to earnings ratio is higher than 7.08% of companies in Healthcare sector

    PB Ratio

    PB ratio

    0.16
    EGRX price to book ratio is 0.16

    PB ratio Sector rank

    18.79%
    EGRX price to book ratio is higher than 18.79% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.16
    EGRX price to sales ratio is 0.16

    PS ratio Sector rank

    5.33%
    EGRX price to sales ratio is higher than 5.33% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $98.66M
    EGRX enterprise value is $98.66 million

    Enterprise value Sector rank

    45.98%
    EGRX enterprise value is higher than 45.98% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    1.53
    EGRX EV/EBITDA is 1.53

    EV/EBITDA Sector rank

    74.66%
    EGRX EV/EBITDA is higher than 74.66% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.70
    EGRX annual current ratio is 1.70

    Quick ratio

    1.22
    EGRX annual quick ratio is 1.22

    Leverage

    Debt to equity

    0.28
    EGRX annual debt to equity ratio is 0.28

    Interest coverage ratio

    -
    EGRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    EGRX piotroski f-score is 5

    Altman Z-Score

    2.30
    EGRX altman z-score is 2.30

    Analyst ratings

    Recent major analysts updates

    Aug 9, 23 Piper Sandler
    Underweight
    Mar 2, 20 Cantor Fitzgerald
    Neutral
    Mar 22, 19 Mizuho
    Neutral
    Oct 31, 18 PiperJaffray
    Neutral
    Oct 31, 18 Piper Sandler
    Neutral
    Sep 21, 18 Cantor Fitzgerald
    Overweight
    Jun 12, 18 Cantor Fitzgerald
    Overweight
    Jun 11, 18 Mizuho
    Neutral
    Jan 9, 17 Mizuho
    Underperform
    Nov 3, 16 Mizuho
    Buy

    Institutional Ownership

    Screeners with EGRX included

    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks with low PE ratio
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for Eagle Pharmaceuticals, Inc.?
    • Does Eagle Pharmaceuticals, Inc. pay dividends?
    • What sector is Eagle Pharmaceuticals, Inc. in?
    • What industry is Eagle Pharmaceuticals, Inc. in?
    • What country is Eagle Pharmaceuticals, Inc. based in?
    • When did Eagle Pharmaceuticals, Inc. go public?
    • Is Eagle Pharmaceuticals, Inc. in the S&P 500?
    • Is Eagle Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Eagle Pharmaceuticals, Inc. in the Dow Jones?
    • When was Eagle Pharmaceuticals, Inc.'s last earnings report?
    • When does Eagle Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Eagle Pharmaceuticals, Inc.?

    The ticker symbol for Eagle Pharmaceuticals, Inc. is NASDAQ:EGRX

    Does Eagle Pharmaceuticals, Inc. pay dividends?

    No, Eagle Pharmaceuticals, Inc. does not pay dividends

    What sector is Eagle Pharmaceuticals, Inc. in?

    Eagle Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Eagle Pharmaceuticals, Inc. in?

    Eagle Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Eagle Pharmaceuticals, Inc. based in?

    Eagle Pharmaceuticals, Inc. is headquartered in United States

    When did Eagle Pharmaceuticals, Inc. go public?

    Eagle Pharmaceuticals, Inc.'s initial public offering (IPO) was on February 12, 2014

    Is Eagle Pharmaceuticals, Inc. in the S&P 500?

    No, Eagle Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Eagle Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Eagle Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Eagle Pharmaceuticals, Inc. in the Dow Jones?

    No, Eagle Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Eagle Pharmaceuticals, Inc.'s last earnings report?

    Eagle Pharmaceuticals, Inc.'s most recent earnings report was on March 15, 2024

    When does Eagle Pharmaceuticals, Inc. report earnings?

    The date for Eagle Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page